Showing 6 of 26 recruiting trials for “Primary peritoneal carcinoma”
Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma
RecruitingNCT04314401 ↗
National Cancer Institute "Cancer Moonshot Biobank"
ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer
Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)
👨⚕️ Tingyan Shi, M.D., Ph.D., Shanghai Gynecologic Oncology Group📍 5 sites📅 Started Oct 2019View details ↗
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
RecruitingNCT00488878 ↗
Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors
← PreviousPage 2 of 2
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →